Intracrine androgens and AKR1C3 activation confer resistance to enzalutamide in prostate cancer

Chengfei Liu, Wei Lou, Yezi Zhu, Joy C. Yang, Nagalakshmi Nadiminty, Nilesh W. Gaikwad, Christopher P Evans, Allen C Gao

Research output: Contribution to journalArticlepeer-review

122 Scopus citations

Fingerprint Dive into the research topics of 'Intracrine androgens and AKR1C3 activation confer resistance to enzalutamide in prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences